I disagree with the second sentence in your post: Since

New Post Public Reply Private Reply Replies (1) Message Board
BruceLake lodge #14378
1,049
I disagree with the second sentence in your post:
Quote:
Since the number of authorized but not issued shares will be proportionately reduced I do not believe we will be less significant in terms of shares held by shareholders.


There seems to be a misunderstanding regarding this. Fact is the number of authorized but not issued shares will NOT be proportionately reduced.

https://seekingalpha.com/filing/4372569

Bottom of page 5 and top of page 6

Quote:
Authorized Shares of Stock

The reverse stock split would affect all issued and outstanding shares of Common Stock and outstanding rights to acquire shares of our Common Stock. We will not change the number of shares of Common Stock currently authorized. However, upon the effectiveness of the reverse stock split, the number of authorized shares of Common Stock that are not issued or outstanding would increase due to the reduction in the number of shares of Common Stock issued and outstanding as a result of the reverse stock split.


This is the part that is problematic. If the # of authorized shares were also reduced proportionally to the R/S then it would be ok.

Quote:
As of February 6, 2019, we had (i) 500,000,000 shares of authorized Common Stock, par value $0.00001 per share, of which 156,897,345 shares of Common Stock were issued and outstanding, and (ii) 20,000,000 shares of authorized preferred stock, par value $0.00001 per share, of which 500 shares were designated as Series A Convertible Preferred Stock, par value $0.00001 per share, and of which 465 shares of Series A Preferred Convertible Preferred Stock were issued and outstanding. If we issue additional shares, the ownership interest of holders of Common Stock will be diluted.


So here is the picture. Right now there are still approximately 343 million share that could be issued. After a R/S of 100-1 the number of shares would be reduced to 1.57 Mil., but now the company would still have room to issue another 498.43 Mil new shares!!

Not sure if the existing loan agreement prevents this type of dilution. You would think so, but if Discovery is paid off then this would be a moot point. However, I can't imagine a new investor being thrilled with such a share structure. Quite likely any new funding would include clear restrictions and consent requirements regarding future dilution.

OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links

OWCP Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Contentious Tesla Pay Package Sparks Investor Outrage

Updated Category News Views 291

Investor Criticism of Tesla's Strategy Investor Ross Gerber, from Gerber Kawasaki Wealth and Investment Management, has raised significant concerns regarding Tesla Inc.'s (NASDAQ: TSLA) current priorities. He highlights that the company seems to spend more on promoting CEO Elon Musk's extravagantly high compensation package rather than addressing its declining vehicle...

Continue Reading
Recent Trends in Spanish Stock Market Close: Key Insights

Updated Category News Views 359

Overview of Recent Market Activity Spain's stock market recently closed lower, reflecting a noticeable decline in various sectors. The trading environment showcased a downturn, particularly influenced by performances in Consumer Goods, Financial Services & Real Estate, and Consumer Services sectors. As market participants adjusted their positions, the IBEX 35 index...

Continue Reading
Opportunity for ASP Isotopes Investors to Join Class Action Lawsuit

Updated Category News Views 141

Class Action Lawsuit Filed Against ASP Isotopes Inc. Recently, Bronstein, Gewirtz & Grossman, LLC, a law firm with a strong reputation in investor advocacy, announced the filing of a class action lawsuit against ASP Isotopes Inc. (NASDAQ: ASPI) and certain individuals associated with the company. This legal action aims to seek justice and recovery for investors who may...

Continue Reading
Innovative Alzheimer’s Research Presented by DiamiR and Aptorum

Updated Category News Views 130

Innovative Alzheimer’s Research Presented by DiamiR and Aptorum DiamiR Biosciences Corp., the developer behind advanced blood-based diagnostic tests for brain health, is stepping into the spotlight along with Aptorum Group Limited (NASDAQ: APM). This exciting collaboration brings forward two compelling poster presentations at an upcoming conference dedicated to...

Continue Reading
La-Z-Boy Incorporated Announces Quarterly Dividend for Investors

Updated Category News Views 106

La-Z-Boy Incorporated Announces Quarterly Dividend La-Z-Boy Incorporated (NYSE: LZB), a leading name in the furniture retail and manufacturing industry, has officially declared a quarterly cash dividend of $0.22 per share. This financial move is indicative of the company's ongoing commitment to delivering value to its shareholders and underscores its robust business...

Continue Reading